Corporate Tech Investors

Pfizer Venture Investments

Pfizer Venture Investments is a corporate VC investing group that partners with technologies that align with its strategic interests.

Venture Investor Overview

Venture Investor
Pfizer Venture Investments
Status
Active
Investor Type
Corporate
Activity Level
Industry Focus
Biopharmaceutical
Healthcare Services
Medical Devices & Instruments

Contact Information

Contact
Albert Bourla
Title
Chief Executive Officer
Mailing Address
235 East 42nd St.
New York, NY 10017
USA
Email Address
Not Recorded

Background Information

Overview
Pfizer Venture Investments (PVI), the venture capital arm of Pfizer, Inc., was founded in 2004 and invests for return in areas of current or future strategic interest to Pfizer. As part of the Worldwide Business Development, Strategy, and Innovation division, PVI seeks to remain at the forefront of life science advances, looking to identify and invest in emerging companies that are developing compounds and technologies that have the potential to enhance Pfizer's pipeline and shape the future of our industry.
Profile
Pfizer Venture Investments LinkedIn Company Profile
Social Media
Pfizer Venture Investments Company Twitter Account
Company News
Pfizer Venture Investments News
Facebook
Pfizer Venture Investments on Facebook
YouTube
Pfizer Venture Investments on YouTube
Last Transaction
5/23/2024

Transaction History

Our records indicate that Pfizer Venture Investments invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
5/23/2024
$50,000,000
3/21/2024
$175,000,000
3/14/2024
$31,720,000
2/27/2024
$51,420,000
1/30/2024
$105,000,000
9/19/2023
$50,000,000
9/6/2023
$210,000,000
7/24/2023
$25,000,000
7/11/2023
$80,000,000
6/7/2023
$25,000,000
4/25/2023
$106,500,000
3/22/2023
$123,000,000
3/15/2023
$105,000,000
1/30/2023
$4,100,000
1/26/2023
$49,000,000
12/14/2022
$30,000,000
11/15/2022
$107,000,000
10/19/2022
$42,220,000
10/18/2022
$35,000,000
9/12/2022
$125,000,000
7/13/2022
$40,500,000
6/23/2022
$70,000,000
6/14/2022
$65,000,000
6/13/2022
$103,000,000
6/7/2022
$74,000,000
4/6/2022
$110,000,000
3/10/2022
$80,000,000
2/18/2022
$64,000,000
11/6/2021
$65,000,000
10/23/2021
$80,000,000
8/19/2021
$50,000,000
7/29/2021
$90,000,000
6/23/2021
$59,000,000
5/19/2021
$76,000,000
3/31/2021
$152,000,000
3/18/2021
Unknown
9/18/2020
$100,000,000
7/16/2020
$72,500,000
7/2/2020
$93,500,000
6/17/2020
$75,000,000
6/10/2020
$76,000,000
5/20/2020
$53,000,000
4/17/2020
$100,000,000
12/18/2019
$59,000,000
11/8/2019
$44,000,000
4/19/2019
$75,000,000
4/2/2019
$125,000,000
3/19/2019
$63,000,000
11/14/2018
$93,000,000
11/14/2018
$65,000,000
9/13/2018
$25,000,000
9/11/2018
$20,000,000
9/6/2018
$90,000,000
8/14/2018
$31,000,000
6/6/2018
$65,000,000
6/1/2018
$76,000,000
5/24/2018
$26,000,000
4/6/2018
$100,000,000
1/10/2018
Unknown
12/16/2017
$50,000,000
10/18/2017
$34,000,000
10/5/2017
$47,600,000
9/26/2017
$103,000,000
7/27/2017
$62,000,000
7/26/2017
$1,100,000
7/25/2017
$38,600,000
6/7/2017
$15,000,000
4/25/2017
$10,000,000
2/18/2017
$41,000,000
1/6/2017
$8,200,000
9/9/2016
$4,000,000
7/26/2016
$17,000,000
6/30/2016
$51,500,000
6/20/2016
$45,000,000
4/20/2016
$42,600,000
4/15/2016
$31,000,000
4/14/2016
$52,000,000
1/25/2016
$10,000,000
1/13/2016
$17,000,000
1/7/2016
$67,000,000
1/7/2016
$48,000,000
7/23/2015
$55,000,000
4/30/2015
$41,800,000
3/18/2015
$43,000,000
3/2/2015
$35,000,000
1/8/2015
$25,000,000
1/6/2015
$20,000,000
10/27/2014
$17,000,000
9/23/2014
Unknown
7/30/2014
$30,000,000
7/23/2014
$3,000,000
6/30/2014
Unknown
4/5/2014
$11,600,000
4/2/2014
$21,000,000
10/18/2013
$15,000,000
4/12/2013
$16,000,000
12/4/2012
$20,000,000
11/27/2012
$8,000,000
11/13/2012
$13,000,000
11/6/2012
Unknown
10/24/2012
$34,500,000
7/31/2012
$27,000,000
2/16/2012
$43,000,000
12/31/2011
$12,000,200
7/14/2011
$14,600,000
5/16/2011
$30,000,000
1/5/2011
$23,000,000
9/27/2010
$5,000,000
6/17/2010
$25,000,000
6/2/2010
$12,000,000
5/20/2010
$43,000,000
3/22/2010
$15,500,000
3/19/2010
$7,000,000
1/29/2010
$9,000,000
5/21/2009
$34,500,000
9/30/2008
$39,000,000
8/4/2008
$19,200,000
6/23/2008
$3,000,000
9/6/2007
$10,000,000
5/9/2007
$26,000,000
3/31/2007
$5,000,000
5/15/2006
$5,600,000
5/12/2006
$8,000,000
8/3/2005
$20,000,000
6/2/2005
$27,000,000
3/31/2005
$5,040,000

 


Investor Contacts

Title
Name
Email & Social
Chief Executive Officer
Albert Bourla
  Albert Bourla LinkedIn Profile  Albert Bourla Twitter Account  Albert Bourla News  Albert Bourla on Facebook

 


Funds

Our database includes the following fund closing(s) for Pfizer Venture Investments. If we are missing funds, please contact us.

Fund Description
Vintage Date
Fund Amount
Fund I
6/6/2018
$600,000,000

 


Portfolio Companies

Pfizer Venture Investments has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company

 

 


 

 

Browse more corporate investors:

PFG | PharmaBio Investments

 

Share this article

 


About Our Corporate VC Database

This corporate tech investor profile is powered by VentureDeal.com, a leading provider of corporate tech investing transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary